DCC-2618 is an orally bioavailable switch pocket control inhibitor of wild-type and mutated forms of KIT and PDGFR with potential antineoplastic activity. It also inhibits several other kinases, including VEGFR2, TIE2, PDGFR-beta and CSF1R, thereby further inhibiting tumor cell growth.
Molecular Weight:
489.47
Purity:
>98.5%
CAS Number:
[1225278-16-9]
Formula:
C26H21F2N5O3
* VAT and and shipping costs not included. Errors and price changes excepted
